STOCK TITAN

Takeda (NYSE: TAK) awards 43,886 RSU-linked ADSs to oncology unit chief

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bitetti Teresa Marie reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical reported that Teresa Marie Bitetti, President of its Oncology Business Unit, received an equity award of 43,886 American Depositary Shares (ADSs) in the form of restricted stock units (RSUs). Each RSU represents the right to receive one ADS if vesting conditions are met.

The RSUs vest in three equal annual installments beginning on July 1, 2027, which means the award is tied to continued service over several years. After this grant, Bitetti directly holds 302,022 ADSs, reflecting her ongoing long-term ownership stake aligned with shareholders.

Positive

  • None.

Negative

  • None.
Insider Bitetti Teresa Marie
Role President, OBU
Type Security Shares Price Value
Grant/Award American Depositary Shares 43,886 $0.00 --
Holdings After Transaction: American Depositary Shares — 302,022 shares (Direct)
Footnotes (1)
  1. [object Object]
RSU grant size 43,886 ADS-equivalent RSUs Award to President, OBU on July 1, 2026
Holdings after transaction 302,022 ADSs Direct ownership after RSU award
Vesting schedule 3 equal annual installments Beginning July 1, 2027
Grant price per share $0.00 per ADS Compensation-related stock unit award
restricted stock units (RSUs) financial
"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
American Depositary Shares financial
"Each RSU represents a contingent right to receive one American Depositary Share."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
vest in three equal annual installments financial
"The RSUs vest in three equal annual installments beginning on July 1, 2027."
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Takeda (TAK) report for Teresa Marie Bitetti?

Takeda reported that Teresa Marie Bitetti received an equity award of 43,886 restricted stock units tied to American Depositary Shares. This is a compensation-related grant, not an open-market purchase or sale, and increases her long-term share-based stake in the company.

How many Takeda (TAK) shares does Teresa Marie Bitetti hold after this Form 4?

Following the RSU award, Teresa Marie Bitetti is shown as holding 302,022 American Depositary Shares directly. This figure reflects her position after the grant, highlighting a substantial ongoing ownership interest linked to Takeda’s future performance.

How do the new RSUs granted to Takeda (TAK) executive Teresa Bitetti vest?

The 43,886 restricted stock units vest in three equal annual installments starting July 1, 2027. Each installment delivers actual American Depositary Shares if service-based vesting conditions are satisfied, encouraging multi-year retention and alignment with shareholder outcomes.

Was Teresa Marie Bitetti’s Takeda (TAK) RSU grant an open-market stock purchase?

No, the filing classifies the transaction as a grant or award acquisition at a price of $0.00 per share. It represents stock-based compensation rather than Bitetti buying shares in the market, with shares delivered only as RSUs vest over time.

What does each RSU represent in Teresa Bitetti’s Takeda (TAK) award?

Each restricted stock unit represents a contingent right to receive one American Depositary Share of Takeda. Delivery occurs only if the vesting schedule is met, so the RSUs function as deferred share-based compensation rather than immediately tradable stock.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bitetti Teresa Marie

(Last)(First)(Middle)
40 LANDSDOWNE STREET

(Street)
CAMBRIDGE MASSACHUSETTS 02139

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President, OBU
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
American Depositary Shares07/01/2026A(1)43,886A$0302,022D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.
Remarks:
/s/ Kate Huleatt, by power of attorney, for Teresa Bitetti07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)